Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

被引：0
|
作者：
Julia Stockmann
Inge M. W. Verberk
Nina Timmesfeld
Robin Denz
Brian Budde
Julia Lange-Leifhelm
Philip Scheltens
Wiesje M. van der Flier
Andreas Nabers
Charlotte E. Teunissen
Klaus Gerwert
机构：
[1] Ruhr-University Bochum,Competence Center for Biospectroscopy, Center for Protein Diagnostics (PRODI)
[2] Ruhr University Bochum,Department of Biophysics
[3] Faculty of Biology and Biotechnology,Neurochemistry Laboratory, Department of Clinical Chemistry
[4] Amsterdam Neuroscience,Alzheimer Center Amsterdam, Department of Neurology
[5] Vrije Universiteit Amsterdam,Ruhr University Bochum, Department of Medical Informatics
[6] Amsterdam Neuroscience,undefined
[7] Vrije Universiteit Amsterdam,undefined
[8] Biometry and Epidemiology,undefined
来源：
Alzheimer's Research & Therapy | / 12卷
关键词：
Alzheimer’s disease; Amyloid beta (Aβ); Blood plasma; Risk stratification; Structure biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline
    Stockmann, Julia
    Verberk, Inge M. W.
    Timmesfeld, Nina
    Denz, Robin
    Budde, Brian
    Lange-Leifhelm, Julia
    Scheltens, Philip
    van der Flier, Wiesje M.
    Nabers, Andreas
    Teunissen, Charlotte E.
    Gerwert, Klaus
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [2] Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
    Julia Stockmann
    Inge M. W. Verberk
    Nina Timmesfeld
    Robin Denz
    Brian Budde
    Julia Lange-Leifhelm
    Philip Scheltens
    Wiesje M. van der Flier
    Andreas Nabers
    Charlotte E. Teunissen
    Klaus Gerwert
    Alzheimer's Research & Therapy, 13
  • [3] Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline (vol 12, 169, 2020)
    Stockmann, Julia
    Verberk, Inge M. W.
    Timmesfeld, Nina
    Denz, Robin
    Budde, Brian
    Lange-Leifhelm, Julia
    Scheltens, Philip
    van der Flier, Wiesje M.
    Nabers, Andreas
    Teunissen, Charlotte E.
    Gerwert, Klaus
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [4] Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease
    Lim, Yen Ying
    Maruff, Paul
    Kaneko, Naoki
    Doecke, James
    Fowler, Christopher
    Villemagne, Victor L.
    Kato, Takashi
    Rowe, Christopher C.
    Arahata, Yutaka
    Iwamoto, Shinichi
    Ito, Kengo
    Tanaka, Koichi
    Yanagisawa, Katsuhiko
    Masters, Colin L.
    Nakamura, Akinori
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (03) : 1057 - 1065
  • [5] Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease
    Chatterjee, Pratishtha
    Elmi, Mitra
    Goozee, Kathryn
    Shah, Tejal
    Sohrabi, Hamid R.
    Dias, Cintia B.
    Pedrini, Steve
    Shen, Kaikai
    Asih, Prita R.
    Dave, Preeti
    Taddei, Kevin
    Vanderstichele, Hugo
    Zetterberg, Henrik
    Blennow, Kaj
    Martins, Ralph N.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (03) : 775 - 783
  • [6] Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease
    Jongbloed, Wesley
    Bruggink, Kim A.
    Kester, Maartje I.
    Visser, Pieter-Jelle
    Scheltens, Philip
    Blankenstein, Marinus A.
    Verbeek, Marcel M.
    Teunissen, Charlotte E.
    Veerhuis, Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 45 (01) : 35 - 43
  • [7] Increases in amyloid-β42 slow cognitive and clinical decline in Alzheimer's disease trials
    Abanto, Jesus
    Dwivedi, Alok K.
    Imbimbo, Bruno P.
    Espay, Alberto J.
    BRAIN, 2024, 147 (10) : 3513 - 3521
  • [8] Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease
    Pivtoraiko, Violetta N.
    Abrahamson, Eric E.
    Leurgans, Sue E.
    DeKosky, Steven T.
    Mufson, Elliott J.
    Ikonomovic, Milos D.
    NEUROBIOLOGY OF AGING, 2015, 36 (01) : 12 - 19
  • [9] Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis
    Zhou, L.
    Chan, K. H.
    Chu, L. W.
    Kwan, J. S. C.
    Song, Y. Q.
    Chen, L. H.
    Ho, P. W. L.
    Cheng, O. Y.
    Ho, J. W. M.
    Lam, K. S. L.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 423 (04) : 697 - 702
  • [10] Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
    Lui, James K.
    Laws, Simon M.
    Li, Qiao-Xin
    Villemagne, Victor L.
    Ames, David
    Brown, Belinda
    Bush, Ashley I.
    De Ruyck, Karl
    Dromey, Jasmin
    Ellis, Kathryn A.
    Faux, Noel G.
    Foster, Jonathan
    Fowler, Christopher
    Gupta, Veer
    Hudson, Peter
    Laughton, Katrina
    Masters, Colin L.
    Pertile, Kelly
    Rembach, Alan
    Rimajova, Mira
    Rodrigues, Mark
    Rowe, Christopher C.
    Rumble, Rebecca
    Szoeke, Cassandra
    Taddei, Kevin
    Taddei, Tania
    Trounson, Brett
    Ward, Vanessa
    Martins, Ralph N.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) : 1233 - 1242
12345